Skip to main content
Figure 3 | Radiation Oncology

Figure 3

From: In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model

Figure 3

Presents In vivo tumor growth of rhabdomyosarcoma (RMS) xenografts after treatment with 10 Gy single dose radiation (XRT) or XRT and SAHA for 8 days (Cohort I). Local failure was defined as a tumor growth > 1000 mm3. Local Control was calculated according to the method of Kaplan and Meier. Fifty days after treatment start.

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us